Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
456 found
Momentum builds for neglected diseases drug discovery
21 Sep 2012
Improving safety for antimalarial drugs
31 Aug 2012
African antimalarial research bears first fruit
28 Aug 2012
New medicine for relapsing malaria being evaluated in four countries
27 Aug 2012
MMV assesses risk of resistance
22 Aug 2012
Eurartesim® reaches Cambodia
19 Jul 2012
MMV supports Asia Pacific malaria forum
19 Jul 2012
MMV and the European Bioinformatics Institute establish one-stop shop for malaria drug data
13 Jul 2012
Scaling-up access to life-saving antimalarials in Nigeria
11 Jul 2012
OZ439 clears the first clinical development hurdle
11 Jul 2012
Pyronaridine/artesunate included in the list of WHO prequalified medicines
15 May 2012
MMV’s Chief Scientific Officer elected to Academy of Medical Sciences
10 May 2012
Former MMV ESAC member receives Gairdner Foundation award
17 Apr 2012
Ian Bathurst Global Health Travel Awards
02 Apr 2012
Sharing the fruits of science to accelerate drug discovery
22 Mar 2012
Rewarding innovative ideas
22 Mar 2012
Double commendation for MMV ESAC member
15 Mar 2012
Delivery of child-friendly antimalarial hits the 100 million mark
22 Feb 2012
One step closer to blocking the transmission of malaria
21 Feb 2012
Pyramax® receives positive opinion from the EMA
20 Feb 2012
Condolence message
10 Feb 2012
Yvonne Chaka Chaka becomes first African woman to receive WEF's Crystal Award
26 Jan 2012
The year in review
16 Jan 2012
Do you have an idea that could revolutionize malaria drug discovery?
12 Jan 2012
Former MMV ESAC member awarded Queen’s New Year Honour
03 Jan 2012
MMV and SCYNEXIS offer 400 active compounds for neglected disease drug research at no cost
19 Dec 2011
U.N. Special Envoy for Malaria, Ray Chambers, and RBM Executive Director, Professor Awa Coll-Seck, awarded “UNCA Citizen of the Year Award”
14 Dec 2011
World Malaria Report 2011 highlights fragile progress
13 Dec 2011
New generation of lifesaving medicines and vaccines for the world’s poor now at risk
08 Dec 2011
MMV delivers testimony to US congress
05 Dec 2011
Marketing authorization for Eurartesim® announced at media roundtable
30 Nov 2011
New dual-acting antimalarial compounds discovered
17 Nov 2011
Partnership reaches important milestone
14 Nov 2011
Eurartesim® receives stringent regulatory approval from the EMA
10 Nov 2011
Patient screening underway for Pyramax® sub-study in Sotuba, Mali
09 Nov 2011
SMS for Life wins WSJ Innovation Award 2011
31 Oct 2011
MMV Symposium at EDCTP
20 Oct 2011
Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities
11 Oct 2011
Launch of the CAPSS Plus Pilot in Uganda
30 Sep 2011
Chinese scientist wins award for life-saving discovery of artemisinin
23 Sep 2011
Molecule moves through preclinical development in record time
02 Sep 2011
MMV ESAC member receives accolade for malaria research
22 Aug 2011
Pyramax® edges closer to patients
19 Aug 2011
The Ian Bathurst Sponsorship Programme
07 Jul 2011
MMV holds malaria session at The World Conference of Science Journalists
01 Jul 2011
MMV loses a dear colleague and friend
28 Jun 2011
Artemisinin’s key impurities identified and made available as reference standards
20 Jun 2011
MMV supports new technique to measure quality of artemisinin
06 Jun 2011
DHODH awarded MMV’s Project of the Year 2010
01 Jun 2011
Ray Chambers takes over from Baroness Chalker as MMV's Chairman
01 Jun 2011
MMV participates in Asia Pacific efforts to eliminate malaria
25 May 2011
Sanofi-aventis and MMV join forces to develop innovative malaria drugs
05 May 2011
Press briefing to mark World Malaria Day
21 Apr 2011
Ray Chambers among TIME's Top 100
21 Apr 2011
"SMS for Life" rolled-out nationwide in the United Republic of Tanzania
18 Apr 2011
MMV’s CEO delivers strong message at Oslo malaria conference
13 Apr 2011
Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria
18 Mar 2011
WHO: Low quality drugs continue to afflict Africa
25 Feb 2011
G-FINDER 2010: Good news with a twist in the tail for PDPs
18 Feb 2011
Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin
15 Feb 2011
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »